Search Results 291-300 of 17750 for cbd

  1. A Study to Evaluate the Need and Impact of a Wellness Program on the Quality of Life, Disease Activity, and Healthcare Utilization in Female IBD (Inflammatory Bowel Disease) Patients - Mayo Clinic

    The purpose of this study assess the current patient practice (standard of care) on Health Related Quality of Life (HRQOL), perceived stress level and disease ...

  2. Midostaurin And Decitabine In Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia And FLT3 Mutation - Mayo Clinic

    This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...

  3. Breast Clinic - Clinical trials

    Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...

  4. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  5. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    This population will be queried for biologic use prior to age 18. The study population for the remainder of the study will be all CD and UC patients in ICN who ...

  6. Pembrolizumab, Lenalidomide, And Dexamethasone In Treating Patients With Newly Diagnosed Multiple Myeloma Eligible For Stem Cell Transplant - Mayo Clinic

    About this study. This phase II trial studies how well pembrolizumab, lenalidomide, and dexamethasone work in treating patients with newly diagnosed ...

  7. A Study To Evaluate The Effectiveness And Safety Of Bb2121 In Subjects With Relapsed And Refractory Multiple Myeloma And In Subjects With Clinical High-Risk Multiple Myeloma - Mayo Clinic

    Cohort 2 will enroll approximately 49 MM subjects with 1 prior anti-myeloma treatment regimen and HR disease defined as Stage III by the Revised International ...

  8. A Study To Evaluate Abemaciclib To Treat Advanced Bone And Soft Tissue Sarcoma Identified As Having CDK Pathway Alteration - Mayo Clinic

    The purpose of this study is to evaluate the 12-week progression free survival (PFS) rate in treated subjects, based on historical sarcoma trial outcomes (PFS ...

  9. Ibrutinib And Ixazomib Citrate In Treating Participants With Relapsed Or Refractory Waldenstrom Macroglobulinemia - Mayo Clinic

    Enzyme inhibitors, such as ibrutinib and ixazomib citrate, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

  10. Epilepsy Clinical Trials - Mayo Clinic Research

    ... CBD) as an Added Treatment for the Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults Scottsdale/Phoenix, AZ. The purpose of this study ...